MRPL48 is a novel prognostic and predictive biomarker of hepatocellular carcinoma
ConclusionsWe demonstrated that MRPL48 expression may be associated with HCC development and prognosis. These findings may open up new research directions and opportunities for the development of HCC treatments.
Source: European Journal of Medical Research - Category: Research Source Type: research
More News: Bone Cancers | Cancer | Cancer & Oncology | Carcinoma | Colorectal Cancer | Eye Cancers | Genetics | Hepatocellular Carcinoma | Liver Cancer | Osteosarcoma | Research | Retinoblastoma | Study